Sign Up to like & get
recommendations!
0
Published in 2019 at "Progress in molecular biology and translational science"
DOI: 10.1016/bs.pmbts.2019.02.003
Abstract: Heparin is an anticoagulant medication that was discovered in 1917 and used in clinic since 1935. Low molecular weight heparins (LMWHs) represent a refined use of heparin as anticoagulant medications that were developed in 1980s.…
read more here.
Keywords:
low molecular;
heparin;
molecular weight;
clinical applications ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Carbohydrate polymers"
DOI: 10.1016/j.carbpol.2016.12.037
Abstract: Low molecular weight heparins (LMWHs) are produced by chemical or enzymatic depolymerization of unfractionated heparin (UFH). Besides their well-known anticoagulant effects, LMWHs have also been reported to exhibit numerous anti-inflammatory properties. Previous studies have, however,…
read more here.
Keywords:
low molecular;
non anticoagulant;
molecular weight;
weight heparins ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Revista Clinica Espanola"
DOI: 10.1016/j.rceng.2016.11.001
Abstract: Abstract In clinical practice, low-molecular-weight heparins are used relatively frequently in patients with atrial fibrillation to prevent embolic events. In this article, it is revised the available evidence in the following clinical situations: rapid onset…
read more here.
Keywords:
atrial fibrillation;
low molecular;
molecular weight;
weight heparins ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2023 at "Medicine"
DOI: 10.1097/md.0000000000033501
Abstract: Rationale: Low molecular weight heparins are widely used in various thrombotic diseases and exert a preventive effect on thrombosis in high-risk patients. Umbilical artery thrombosis (UAT) is a rare occurrence that is difficult to detect…
read more here.
Keywords:
weight heparins;
age;
molecular weight;
thrombosis ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Plastic and reconstructive surgery"
DOI: 10.1097/prs.0000000000010695
Abstract: SUMMARY Venous thromboembolism can present with devastating complications and sequalae, particularly in the surgical patient. Current data supports prophylactic anticoagulant use in the high-risk inpatient, defined as those with a 2005 Caprini Risk Assessment Model…
read more here.
Keywords:
plastic reconstructive;
weight heparins;
molecular weight;
reconstructive surgery ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Science Translational Medicine"
DOI: 10.1126/scitranslmed.aan5954
Abstract: A synthetic homogeneous low–molecular weight heparin provides a safe and effective therapeutic alternative. A reliable animal-free heparin drug Full-sized and low–molecular weight heparins are widely used to treat a variety of clotting disorders. Although low–molecular…
read more here.
Keywords:
low molecular;
heparin;
animal sourced;
molecular weight ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2017.00142
Abstract: Patients with cancer are at significantly higher risk of developing, and dying from, venous thromboembolism (VTE). The CLOT trial demonstrated superiority of low-molecular-weight heparins (LMWH) over warfarin for recurrent VTE and established LMWH as the…
read more here.
Keywords:
low molecular;
venous thromboembolism;
molecular weight;
weight heparins ... See more keywords